AGGRESSIVE LYMPHOMA
Clinical trials for AGGRESSIVE LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new AGGRESSIVE LYMPHOMA trials appear
Sign up with your email to follow new studies for AGGRESSIVE LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immune-Guiding antibody aims to clean up remaining cancer cells after transplant
Disease control OngoingThis early-phase study tests whether adding mosunetuzumab after a stem cell transplant is safe for people with aggressive B cell lymphoma that has come back or not responded to prior treatments. Mosunetuzumab is an engineered antibody that helps the body's T cells recognize and k…
Matched conditions: AGGRESSIVE LYMPHOMA
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Off-the-Shelf cell therapy takes on tough blood cancers
Disease control OngoingThis early-stage trial is testing an experimental therapy called NKX019 for people with certain blood cancers (like lymphoma and leukemia) that have come back or not responded to standard treatments. NKX019 uses donor immune cells (natural killer cells) that are engineered to fin…
Matched conditions: AGGRESSIVE LYMPHOMA
Phase: PHASE1 • Sponsor: Nkarta, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
CAR-T therapy's long-term brain effects to be studied
Knowledge-focused TerminatedThis pilot study aimed to see if it is possible to use neuropsychological tests to measure thinking, memory, and emotional health in adults who received CAR-T therapy for aggressive lymphoma at least six months earlier. The study was withdrawn before enrolling any participants, s…
Matched conditions: AGGRESSIVE LYMPHOMA
Phase: NA • Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC